The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Pharmacogenomics Genome Wise Association Clinical Studies
Abstract
Pharmacogenomics deals with drug responses in individual based on genetic variation in genome. Based on genetic variations, drugs may produce more or less therapeutic effect, and same way in side effects also. Physicians can use information about your genetic makeup to choose those drugs and drug doses to get better therapy. Optimizing drug therapy and rational dose adjustment with respect to genetic makeup will maximize drug efficacy and minimal adverse effects. This broken traditional ‘trial and error' method of ‘one drug fits all', and ‘one dose fits all' which contributing to 25–50% of drug toxicity or treatment failures. This will contribute to improve the ways in which existing drugs are used, genomic research will lead to drug development to produce new drugs that are highly effective without serious side effects. This approach to bring personalized medicine more practice and drug combinations are optimized for each individual' genetic makeup.
Related Content
|
Kusum Payal, Kottapalli S. Rao, R. K. Maikhuri, L. S. Kandari.
© 2020.
16 pages.
|
|
Bimal K. Chetri, Namgay Rinchen, Karma Wangchuck.
© 2020.
21 pages.
|
|
Akash, Navneet Navneet, Bhupendra Singh Bhandari, Surendra Singh Bisht, Dalip Kumar Mansotra.
© 2020.
20 pages.
|
|
Uday Kumar Sen, Ram Kumar Bhakat.
© 2020.
23 pages.
|
|
Mohammed Rahmatullah, Khoshnur Jannat, Gerald R. Reeck, Rownak Jahan, Taufiq Rahman, Nasrin A. Shova, Maidul Islam.
© 2020.
23 pages.
|
|
Martha B. Ramírez-Rosas, Adriana L. Perales-Torres, Rubén Santiago-Adame.
© 2020.
26 pages.
|
|
Anish Nag.
© 2020.
23 pages.
|
|
|